Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-23 Sale | 2024-07-25 4:05 pm | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 23,625 | $3.1674 | $74,830 | 118,693 (Direct) | View |
| 2024-07-19 Sale | 2024-07-23 4:06 pm | Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer | 8,357 | $3.1004 | $25,910 | 81,213 (Direct) | View |
| 2024-07-19 Sale | 2024-07-23 4:05 pm | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO | 10,914 | $3.0997 | $33,830 | 160,506 (Direct) | View |
| 2024-07-19 Sale | 2024-07-23 4:05 pm | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 14,062 | $3.1009 | $43,605 | 142,318 (Direct) | View |
| 2024-03-26 Purchase | 2024-03-28 4:08 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 12,100 | $5.267 | $63,731 | 639,200 (Direct) | View |
| 2023-12-07 Purchase | 2023-12-08 4:05 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 1,600 | $4.1 | $6,560 | 627,100 (Direct) | View |
| 2023-11-16 Purchase | 2023-11-20 9:59 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 590 | $2.35 | $1,387 | 590 (Direct) | View |
| 2023-07-18 Purchase | 2023-07-20 6:56 pm | Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 30,000 | $16 | $480,000 | 3,925,627 (Direct) | View |
| 2023-07-18 Sale | 2023-07-20 6:56 pm | Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 662 | $16 | $10,592 | 3,925,627 (Direct) | View |
| 2023-07-18 Purchase | 2023-07-20 4:20 pm | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 46,875 | $16 | $750,000 | 154,859 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-01 Option Award | 2024-08-05 4:09 pm | N/A 2034-07-31 | Sagimet Biosciences Inc. | SGMT | Jarrett Jennifer Director | 113,895 | $0 | 113,895 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 4:08 pm | N/A 2034-07-31 | Sagimet Biosciences Inc. | SGMT | Phillips Anne M. Director | 113,895 | $0 | 113,895 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:08 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director | 9,279 | $0 | 9,279 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:07 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 51,459 | $0 | 51,459 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:07 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | Parsey Merdad Director | 51,459 | $0 | 51,459 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:05 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director | 9,279 | $0 | 9,279 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:05 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | GRAMMER ELIZABETH A Director | 51,459 | $0 | 51,459 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-08 4:06 pm | N/A 2034-05-05 | Sagimet Biosciences Inc. | SGMT | Chauche Thierry Chief Financial Officer | 587,181 | $0 | 587,181 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:19 pm | N/A 2034-03-31 | Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director | 73,014 | $0 | 73,014 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:17 pm | N/A 2034-03-31 | Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director | 73,014 | $0 | 73,014 (Direct) | View |
Ownership | 2024-04-03 8:15 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director | 0 | $0 | 2,200 (Direct) | View |
| 2024-01-29 Other | 2024-01-31 5:00 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | SANDELL SCOTT D 10% Owner | 1,117,947 | $0 | 1,385,894 (Indirect) | View |
| 2024-01-29 Other | 2024-01-31 4:59 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | KERINS PATRICK J 10% Owner | 1,124,089 | $0 | 1,398,178 (Indirect) | View |
| 2024-01-29 Other | 2024-01-31 4:57 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | BASKETT FOREST 10% Owner | 1,122,250 | $0 | 1,394,500 (Indirect) | View |
| 2024-01-29 Other | 2024-01-31 4:56 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 1,110,950 | $0 | 4,372,175 (Indirect) | View |
| 2024-01-29 Other | 2024-01-31 4:55 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner | 850,000 | $0 | 3,850,275 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-21 4:25 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO | 171,420 | $0 | 171,420 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-21 4:23 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer | 89,570 | $0 | 89,570 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-21 4:22 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 150,750 | $0 | 156,380 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-21 4:21 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 624,910 | $0 | 625,500 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-08 4:15 pm | N/A 2023-09-26 | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 5,630 | $0 | 5,630 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-08 4:15 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 5,630 | $0.79 | 5,630 (Direct) | View |
| 2023-07-18 Conversion | 2023-07-20 6:56 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 303,392,779 | $0 | 3,925,627 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-20 6:56 pm | N/A 2024-01-23 | Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 13,404 | $0 | 3,925,627 (Direct) | View |
| 2023-07-18 Other | 2023-07-20 6:56 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 37,676 | $0 | 3,925,627 (Direct) | View |
| 2023-07-18 Exercise | 2023-07-20 6:56 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 13,404 | $0.7948 | 3,925,627 (Direct) | View |
| 2023-07-18 Conversion | 2023-07-20 4:20 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | KPCB PBD Associates LLC KPCB PANDEMIC & BIO DEFENSE FUND LLC 10% Owner | 149,747,188 | $0 | 1,977,001 (Indirect) | View |
| 2023-07-18 Other | 2023-07-20 4:20 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | KPCB PBD Associates LLC KPCB PANDEMIC & BIO DEFENSE FUND LLC 10% Owner | 38,763 | $0 | 1,977,001 (Indirect) | View |
| 2023-07-18 Conversion | 2023-07-20 4:20 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 156,569,210 | $0 | 154,859 (Indirect) | View |
| 2023-07-18 Option Award | 2023-07-20 4:20 pm | N/A 2029-04-28 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 61,979 | $0 | 154,859 (Direct) | View |
| 2023-07-18 Disposition | 2023-07-20 4:20 pm | N/A 2029-04-28 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 61,979 | $0 | 154,859 (Direct) | View |
| 2023-07-18 Conversion | 2023-07-20 4:19 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Wu Jinzi Jason Director | 133,167,809 | $0 | 1,677,917 (Indirect) | View |
| 2023-07-18 Option Award | 2023-07-20 4:19 pm | N/A 2029-04-27 | Sagimet Biosciences Inc. | SGMT | Wu Jinzi Jason Director | 23,216 | $0 | 1,677,917 (Direct) | View |
| 2023-07-18 Disposition | 2023-07-20 4:19 pm | N/A 2029-04-27 | Sagimet Biosciences Inc. | SGMT | Wu Jinzi Jason Director | 23,216 | $0 | 1,677,917 (Direct) | View |
| 2023-07-18 Option Award | 2023-07-20 4:19 pm | N/A 2033-04-19 | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO | 242,142 | $0 | 242,142 (Direct) | View |
| 2023-07-18 Disposition | 2023-07-20 4:19 pm | N/A 2033-04-19 | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO | 242,142 | $0 | 242,142 (Direct) | View |
| 2023-07-18 Option Award | 2023-07-20 4:18 pm | N/A 2025-03-09 | Sagimet Biosciences Inc. | SGMT | Rodgers Richard J Director | 49,031 | $0 | 49,031 (Direct) | View |
| 2023-07-18 Disposition | 2023-07-20 4:18 pm | N/A 2025-03-09 | Sagimet Biosciences Inc. | SGMT | Rodgers Richard J Director | 49,031 | $0 | 49,031 (Direct) | View |
| 2023-07-18 Option Award | 2023-07-20 4:18 pm | N/A 2033-04-19 | Sagimet Biosciences Inc. | SGMT | Rimac Anthony M Chief Operating Officer | 242,142 | $0 | 242,142 (Direct) | View |
| 2023-07-18 Disposition | 2023-07-20 4:18 pm | N/A 2033-04-19 | Sagimet Biosciences Inc. | SGMT | Rimac Anthony M Chief Operating Officer | 242,142 | $0 | 242,142 (Direct) | View |